Ignite Creation Date:
2024-05-05 @ 9:55 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00992745
Status:
COMPLETED
Last Update Posted:
2011-10-12
First Post:
2009-10-08
Brief Title:
A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc
Organization Data
Organization:
Molecular Insight Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
TX-P103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Molecular Insight Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None